Motus GI Announces Improvement of Pure-Vu® EVS System for Use in Upper Gastrointestinal (GI) Bleeding Procedures Following Successful Pre-Clinical Tests

Read Release

Motus GI Reports Third Quarter 2022 Financial Results and Provides Business Update

Read Release

Motus GI to Release Third Quarter Results and Provide a Business Update on November 14

Read Release

Motus GI Announces Positive Clinical Data for Pure-Vu EVS in Three Poster Presentations at the American College of Gastroenterology (ACG) 2022 Annual Scientific Meeting

Read Release

Motus GI Granted a U.S. Patent for Prepless Colonoscopy Methods Embodied by the Pure-Vu® System

Read Release

Motus GI Named a Sole Source Supplier with U.S. Department of Veteran Affairs

Read Release

Motus GI Reports Second Quarter 2022 Financial Results and Provides Business Update

Read Release

Motus GI Regains Compliance with Nasdaq Minimum Bid Price Requirement

Read Release

Motus GI Announces 1-FOR-20 Reverse Stock Split

Read Release
RSS